FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to medicine preparations that are used for treatment of opiomania or opiate dependence being especially heroin dependence. Diamorphine and/or one of pharmaceutically acceptable salts addition of acid are used as active substance. Also, invention relates to a method for treatment of opiate dependence. Invention provides the more long release of an active substance that is not decomposed and not loss activity in storing.
EFFECT: enhanced effectiveness of preparation, valuable medicinal properties.
12 cl, 1 tbl, 2 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORGANIC COMPOUNDS | 2018 |
|
RU2777366C2 |
| ORGANIC COMPOUNDS | 2018 |
|
RU2780002C2 |
| DRUG COMBINATION WITH THEOBROMINE AND USE THEREOF IN TREATMENT | 2010 |
|
RU2587329C2 |
| METHOD FOR TREATING THE CASES OF DRUG ADDICTION | 2003 |
|
RU2288717C2 |
| COMPOSITION FOR TERMINATION OF OPIATE ABSTINENT SYNDROME MANIFESTATIONS | 2007 |
|
RU2323725C1 |
| ANALGESIC SUBSTANCE OF ENDOGENOUS NATURE, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS OF USE THEREOF | 2023 |
|
RU2823100C2 |
| METHOD OF TREATING DRUG ABUSE | 2009 |
|
RU2446838C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DRUG DEPENDENCE | 2011 |
|
RU2546522C2 |
| SYNTHETIC IMMUNOGEN FOR THERAPY AND PROPHYLAXIS OF ADDICTION WITH NARCOTIC AND PSYCHOACTIVE SUBSTANCES | 2003 |
|
RU2236257C1 |
| BUPRENOPHINE DERIVATIVES AND APPLICATION THEREOF | 2007 |
|
RU2435773C2 |
